Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jennifer Phan

Gastroenterology Newport Beach, CA Medical Doctor

NPI 1780002055 CMS profile 5691698

1 Hoag Dr, Newport Beach, CA 92663

Open in the dashboard

General payments

$225,640

279 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$67,168 paid to institutions, not to them · program years 2022–2023

Through program year 2025, Jennifer Phan of Newport Beach, CA is reported in the CMS Open Payments database as having received $225,640 across 279 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $67,168 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $31,423 53
2024 General $43,836 60
2023 General $27,310 52
2022 General $56,330 73
2021 General $15,531 32
2020 General $50,000 1
2019 General $1,210 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jennifer Phan
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Jennifer Phan were reported at $31,423. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Jennifer Phan Gastroenterology median Middle half National median
2019 $1,210 $417 $126–$1,100 $163
2020 $50,000 $224 $74–$624 $114
2021 $15,531 $352 $106–$1,054 $132
2022 $56,330 $448 $129–$1,270 $149
2023 $27,310 $533 $150–$1,390 $160
2024 $43,836 $605 $160–$1,606 $164
2025 $31,423 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $190,561 183 payments
  2. Wilson Cook Medical Incorporated $13,121 5 payments
  3. Olympus Corporation of the Americas $4,980 19 payments
  4. Olympus Medical Systems Corporation $4,219 5 payments
  5. Cook Incorporated $3,255 2 payments
  6. Olympus America Inc. $2,866 5 payments
  7. Cook Medical LLC $1,397 18 payments
  8. Apollo Endosurgery US Inc $1,171 15 payments
  9. US Endoscopy $1,000 1 payment
  10. Olympus Corporation $840 1 payment
  11. Other $2,231 25 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $127,610 64 payments
  2. Grant $50,000 1 payment
  3. Consulting Fee $27,239 13 payments
  4. Travel and Lodging $11,926 68 payments
  5. Food and Beverage $8,865 133 payments
Products named General payments · program years 2019–2025
  1. GENERAL - BILIARY DEVICES Biliary Devices $54,578 7 payments
  2. General - Therapies $25,030 20 payments
  3. General - Biliary Devices General - Biliary Devices_ENDO $18,185 16 payments
  4. EXALT Model D EXALT Model D_ENDO $16,678 13 payments
  5. SpyGlass Spyglass DS_ENDO $15,540 10 payments
  6. EXALT Model D EXALT Model D_ENDO $13,818 16 payments
  7. Hemospray $9,093 12 payments
  8. SpyGlass SpyGlass_ENDO $8,109 13 payments
  9. SpyBite $6,084 3 payments
  10. FUSION $6,045 1 payment
  11. Other $35,114 186 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

57

Median for Gastroenterology: 569

Drug cost

$568

Median for Gastroenterology: $104,976

Branded share of claims

0%

Median for Gastroenterology: 31.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Omeprazole Generic 45 $454
Pantoprazole Sodium Generic 12 $114

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,294 Part D prescribers listed as Gastroenterology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 50 billing codes

Paid by Medicare

$40,088

Medicare's payments for the services billed

Medicare patients

155

Average age 70

Services billed

308

86 women, 69 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 63%
Ischemic heart disease 43%
Diabetes 40%
Chronic kidney disease 33%
Depression 30%
Cancer 28%
Heart failure 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

279 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record